BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38424293)

  • 21. Aberrant NSG1 Expression Promotes Esophageal Squamous Cell Carcinoma Cell EMT by the Activation of ERK Signaling Pathway.
    Lin X; Tu M; Zhang Y; Zhuang W; Cai L; Zhang L; Yu L; Zhang Z; Huang Y
    Dig Dis Sci; 2023 May; 68(5):1847-1857. PubMed ID: 36396779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-133b inhibits cell proliferation, migration and invasion of esophageal squamous cell carcinoma by targeting EGFR.
    Zeng W; Zhu JF; Liu JY; Li YL; Dong X; Huang H; Shan L
    Biomed Pharmacother; 2019 Mar; 111():476-484. PubMed ID: 30594787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serine/threonine-protein kinase D2-mediated phosphorylation of DSG2 threonine 730 promotes esophageal squamous cell carcinoma progression.
    Liu YQ; Xu YW; Zheng ZT; Li D; Hong CQ; Dai HQ; Wang JH; Chu LY; Liao LD; Zou HY; Li EM; Xie JJ; Fang WK
    J Pathol; 2024 May; 263(1):99-112. PubMed ID: 38411280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cystathionine-β-synthase (CBS)/H2S system promotes lymph node metastasis of esophageal squamous cell carcinoma (ESCC) by activating SIRT1.
    Liu Y; Pan L; Li Y; Deng Y; Han X; Fu H; Wang T
    Carcinogenesis; 2022 May; 43(4):382-392. PubMed ID: 34994384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PAI-1 overexpression promotes invasion and migration of esophageal squamous carcinoma cells.
    Wang D; Yang LY; Liu Z; Yu J; Zhang MJ; Zhang Y; Cai Y; Xu X; Hao JJ; Wang MR
    Yi Chuan; 2020 Mar; 42(3):287-295. PubMed ID: 32217514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autocrine Leukemia Inhibitory Factor Promotes Esophageal Squamous Cell Carcinoma Progression via Src Family Kinase-Dependent Yes-Associated Protein Activation.
    Kawazoe T; Saeki H; Oki E; Oda Y; Maehara Y; Mori M; Taniguchi K
    Mol Cancer Res; 2020 Dec; 18(12):1876-1888. PubMed ID: 33004621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RASSF6-TRIM16 axis promotes cell proliferation, migration and invasion in esophageal squamous cell carcinoma.
    Zheng L; Zhao Z; Rong L; Xue L; Song Y
    J Genet Genomics; 2019 Oct; 46(10):477-488. PubMed ID: 31812473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IFI6 depletion inhibits esophageal squamous cell carcinoma progression through reactive oxygen species accumulation via mitochondrial dysfunction and endoplasmic reticulum stress.
    Liu Z; Gu S; Lu T; Wu K; Li L; Dong C; Zhou Y
    J Exp Clin Cancer Res; 2020 Jul; 39(1):144. PubMed ID: 32727517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
    Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
    Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
    [No Abstract]   [Full Text] [Related]  

  • 30. The PSMD14 inhibitor Thiolutin as a novel therapeutic approach for esophageal squamous cell carcinoma through facilitating SNAIL degradation.
    Jing C; Li X; Zhou M; Zhang S; Lai Q; Liu D; Ye B; Li L; Wu Y; Li H; Yue K; Chen P; Yao X; Wu Y; Duan Y; Wang X
    Theranostics; 2021; 11(12):5847-5862. PubMed ID: 33897885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circ-ATIC Serves as a Sponge of miR-326 to Accelerate Esophageal Squamous Cell Carcinoma Progression by Targeting ID1.
    Zhang B; Chu W; Li Z; Zhang Y; Zhen Q; Lv B; Liu J; Lu C; Zhao X
    Biochem Genet; 2022 Oct; 60(5):1585-1600. PubMed ID: 35064360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ERK expression and its correlation with STAT1 in esophageal squamous cell carcinoma.
    Wang H; Zhang Y; Yun H; Chen S; Chen Y; Liu Z
    Oncotarget; 2017 Jul; 8(28):45249-45258. PubMed ID: 28431406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silencing of Long Noncoding RNA SNHG6 Inhibits Esophageal Squamous Cell Carcinoma Progression via miR-186-5p/HIF1α Axis.
    Du F; Guo T; Cao C
    Dig Dis Sci; 2020 Oct; 65(10):2844-2852. PubMed ID: 31853782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA CASC9 promotes esophageal squamous cell carcinoma metastasis through upregulating LAMC2 expression by interacting with the CREB-binding protein.
    Liang Y; Chen X; Wu Y; Li J; Zhang S; Wang K; Guan X; Yang K; Bai Y
    Cell Death Differ; 2018 Nov; 25(11):1980-1995. PubMed ID: 29511340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circular RNA hsa_circ_0000654 promotes esophageal squamous cell carcinoma progression by regulating the miR-149-5p/IL-6/STAT3 pathway.
    Xu Z; Tie X; Li N; Yi Z; Shen F; Zhang Y
    IUBMB Life; 2020 Mar; 72(3):426-439. PubMed ID: 31778020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. KISS-1, Mediated by Promoter Methylation, Suppresses Esophageal Squamous Cell Carcinoma Metastasis via MMP2/9/MAPK Axis.
    Duan H; Ding X; Luo H
    Dig Dis Sci; 2022 Oct; 67(10):4780-4796. PubMed ID: 34993679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of microRNA-182-5p on cell proliferation and invasion of esophageal squamous cell carcinoma and related molecular mechanisms].
    Zhu ZQ; Hu HF; Zheng XY; Wang F
    Zhonghua Zhong Liu Za Zhi; 2020 Aug; 42(8):635-643. PubMed ID: 32867454
    [No Abstract]   [Full Text] [Related]  

  • 39. FAT1 prevents epithelial mesenchymal transition (EMT) via MAPK/ERK signaling pathway in esophageal squamous cell cancer.
    Hu X; Zhai Y; Kong P; Cui H; Yan T; Yang J; Qian Y; Ma Y; Wang F; Li H; Cheng C; Zhang L; Jia Z; Li Y; Yang B; Xu E; Wang J; Yang J; Bi Y; Chang L; Wang Y; Zhang Y; Song B; Li G; Shi R; Liu J; Zhang M; Cheng X; Cui Y
    Cancer Lett; 2017 Jul; 397():83-93. PubMed ID: 28366557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CCL3-CCR5 axis contributes to progression of esophageal squamous cell carcinoma by promoting cell migration and invasion via Akt and ERK pathways.
    Kodama T; Koma YI; Arai N; Kido A; Urakawa N; Nishio M; Shigeoka M; Yokozaki H
    Lab Invest; 2020 Sep; 100(9):1140-1157. PubMed ID: 32457351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.